Skip to content
healthcare.dev
Get a free key

TEMOZOLOMIDE

NDC 16571-819, temozolomide, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-819
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206309
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-819 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEMOZOLOMIDE140 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
16571-819-021657108190220 CAPSULE in 1 BOTTLE (16571-819-02)
16571-819-411657108194114 CAPSULE in 1 BOTTLE (16571-819-41)
16571-819-51165710819515 CAPSULE in 1 BOTTLE (16571-819-51)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/70996a9d-4a4f-4ed1-ab07-130486aa14ab

Use it

Look up 16571-819 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-819 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-819. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.